Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core

Ravi TripathiDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USAView further author information

Abiodun AnifowoseDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USAView further author information

Wen LuDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USAView further author information

Xiaoxiao YangDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USACorrespondence[email protected]
View further author information

Binghe WangDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USACorrespondence[email protected]

https://orcid.org/0000-0002-2200-5270 View further author information

Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date